参考文献/References:
[1] KIAMANESH D,RUMLEY J,MOITRA V K.Monitoring and managing hepatic disease in anaesthesia[J].Br J Anaesth,2013,111(1):50-61.
[2] 谭建荣,罗显克,王大东,等.肝硬化患者血清胆碱酯酶和腺苷脱氨酶联合检测的临床意义[J].现代生物医学进展,2014,14(8):1494-1496.
TAN Jianrong,LUO Xianke,WANG Dadong,et al.The clinical significance of cirrhosis combined detection serum cholinesterase and adenosine deaminase[J].Progress in Modern Biomedicine,2014,14(8):1494-1496.
[3] 马正甲.血清胆碱酯酶测定在重症肝炎病情判断中的应用价值[J].检验医学与临床,2013,10(9):1141-1142.
MA Zhengjia.Application value of serum cholinesterase determinationin judging the severity of severe hepatitis[J].Laboratory Medicine and Clinic,2013,10(9):1141-1142.
[4] ZABIHI E,SHABANZADEH M,ARABSHEIBANI S,et al.Pseudo-cholinesterase polymorphism in Mazandaran province(North of Iran)[J].Caspian J Intern Med,2012,3(3):473-477.
[5] DELACOUR H,LUSHCHEKINA S,MABBOUX I,et al.Characterization of a novelbutyrylcholinesterase point mutation(p.Ala34Val),“silent”with mivacurium[J].Biochem Pharmacol,2014,92(3):476-483.
[6] CASSEL J,STAEHR-RYE A K,NIELSEN C V,et al.Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium:three case reports[J].Acta Anaesthesiol Scand,2014,58(8):1040-1043.
[7] 赵启东,刘斌.非去极化肌松药在特殊病人的临床应用进展[J].现代临床医学,2009,35(5):394-397.
ZHAO Qidong,LIU Bin.Progress in the clinical application of non-depolarizing muscle relaxants in special patients[J].Journal of Modern Clinical Medicine,2009,35(5):394-397.
[8] DEVLIN J C,HEAD-RAPSON A G,PARKER C J,et al.Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis[J].Br J Anaesth,1993,71(2):227-231.
相似文献/References:
[1]杨渝伟,黄玉霞,陈小红,等.胱抑素C及其eGFR方程在诊断肝硬化患者肾损害中的应用[J].现代检验医学杂志,2016,31(04):24.[doi:10.3969/j.issn.16717-414.2016.04.006]
YANG Yu-wei,HUANG Yu-xia,CHEN Xiao-hong,et al.Clinical Application of Cystatin C and It's eGFR Equation
for Diagnosing Kidney Injure in Patients with Liver Cirrhosis[J].Journal of Modern Laboratory Medicine,2016,31(05):24.[doi:10.3969/j.issn.16717-414.2016.04.006]
[2]刘昌贺,李 衡,徐圣杰,等.肝硬化伴肝性脑病与血清IL-6表达水平相关性的meta分析[J].现代检验医学杂志,2022,37(03):56.[doi:10.3969/j.issn.1671-7414.2022.03.012]
LIU Chang-he,LI Heng,XU Sheng-jie,et al.Meta Analysis of the Correlation between Serum Interleukin-6 and Hepatic Encephalopathy in Liver Cirrhosis[J].Journal of Modern Laboratory Medicine,2022,37(05):56.[doi:10.3969/j.issn.1671-7414.2022.03.012]
[3]赵佳慧,余 雯.乙型肝炎肝硬化患者血清miR-25-3p 和IBSP 表达及临床意义[J].现代检验医学杂志,2022,37(04):96.[doi:10.3969/j.issn.1671-7414.2022.04.019]
ZHAO Jia-hui,YU Wen.Expression and Clinical Significance of Serum miR-25-3p and IBSP in Patients with Hepatitis B Cirrhosis[J].Journal of Modern Laboratory Medicine,2022,37(05):96.[doi:10.3969/j.issn.1671-7414.2022.04.019]
[4]冯 瑾,魏绪仓.肝硬化患者骨髓造血系统异常的机制研究进展及其骨髓细胞学检查的临床意义[J].现代检验医学杂志,2023,38(02):200.[doi:10.3969/j.issn.1671-7414.2023.02.038
]
FENG Jin,WEI Xu-cang.Research Progress on the Mechanism of Bone Marrow Hematopoietic System Abnormalities in Patients with Liver Cirrhosis and Its Clinical Significance of Bone Marrow Cytology[J].Journal of Modern Laboratory Medicine,2023,38(05):200.[doi:10.3969/j.issn.1671-7414.2023.02.038
]
[5]武 倩,李 英,马燕粉,等.丙型肝炎肝硬化患者进展为肝细胞肝癌预测模型建立及验证[J].现代检验医学杂志,2024,39(05):6.[doi:10.3969/j.issn.1671-7414.2024.05.002]
WU Qian,LI Ying,MA Yanfen,et al.Establishment and Validation of Prediction Model for Hepatocellular Carcinoma Progression in Patients with Hepatitis C Cirrhosis[J].Journal of Modern Laboratory Medicine,2024,39(05):6.[doi:10.3969/j.issn.1671-7414.2024.05.002]